Matches in SemOpenAlex for { <https://semopenalex.org/work/W3183253339> ?p ?o ?g. }
- W3183253339 endingPage "51" @default.
- W3183253339 startingPage "44" @default.
- W3183253339 abstract "Cognitive deficits and negative symptoms in schizophrenia are associated with poor functional outcomes and limited in terms of treatment. The Schizophrenia Treatment With Electric Transcranial Stimulation (STARTS) trial has shown efficacy of transcranial direct current stimulation (tDCS) for improving negative symptoms. In this secondary analysis, we investigate its effects on cognitive performance. In STARTS, a double-blinded, sham-controlled, randomized clinical trial, patients were treated with twice-daily, 20-min, 2-mA fronto-temporal tDCS over 5 days or sham-tDCS. In 90 patients, we evaluated the cognitive performance up to 12 weeks post-treatment. We found that active-tDCS showed no beneficial effects over sham-tDCS in any of the tests. Based on a 5-factor cognitive model, improvements of executive functions and delayed memory were observed in favor of sham-tDCS. Overall, the applied active-tDCS protocol, primarily designed to improve negative symptoms, did not promote cognitive improvement. We discuss possible protocol modification potentially required to increase tDCS effects on cognition. ClinicalTrials.gov identifier: NCT02535676." @default.
- W3183253339 created "2021-08-02" @default.
- W3183253339 creator A5002643809 @default.
- W3183253339 creator A5007764412 @default.
- W3183253339 creator A5029245216 @default.
- W3183253339 creator A5032603473 @default.
- W3183253339 creator A5033148517 @default.
- W3183253339 creator A5033587887 @default.
- W3183253339 creator A5033863280 @default.
- W3183253339 creator A5052305997 @default.
- W3183253339 creator A5063506824 @default.
- W3183253339 creator A5070078265 @default.
- W3183253339 creator A5085753285 @default.
- W3183253339 date "2021-09-01" @default.
- W3183253339 modified "2023-09-30" @default.
- W3183253339 title "Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial" @default.
- W3183253339 cites W1778289017 @default.
- W3183253339 cites W1913957972 @default.
- W3183253339 cites W1964510658 @default.
- W3183253339 cites W1971223956 @default.
- W3183253339 cites W1975960737 @default.
- W3183253339 cites W1981745937 @default.
- W3183253339 cites W1983805722 @default.
- W3183253339 cites W1984615306 @default.
- W3183253339 cites W1985202323 @default.
- W3183253339 cites W1996240273 @default.
- W3183253339 cites W1999062438 @default.
- W3183253339 cites W2005092827 @default.
- W3183253339 cites W2005900392 @default.
- W3183253339 cites W2008062633 @default.
- W3183253339 cites W2010654188 @default.
- W3183253339 cites W2028257011 @default.
- W3183253339 cites W2033343745 @default.
- W3183253339 cites W2033426419 @default.
- W3183253339 cites W2048532846 @default.
- W3183253339 cites W2050298078 @default.
- W3183253339 cites W2060529079 @default.
- W3183253339 cites W2065759841 @default.
- W3183253339 cites W2067877506 @default.
- W3183253339 cites W2079077674 @default.
- W3183253339 cites W2087384984 @default.
- W3183253339 cites W2088457937 @default.
- W3183253339 cites W2089811587 @default.
- W3183253339 cites W2097273459 @default.
- W3183253339 cites W2103655132 @default.
- W3183253339 cites W2104177392 @default.
- W3183253339 cites W2104255009 @default.
- W3183253339 cites W2114329358 @default.
- W3183253339 cites W2128618461 @default.
- W3183253339 cites W2130818116 @default.
- W3183253339 cites W2131983564 @default.
- W3183253339 cites W2158026972 @default.
- W3183253339 cites W2165530068 @default.
- W3183253339 cites W2167827175 @default.
- W3183253339 cites W2170883616 @default.
- W3183253339 cites W2172250870 @default.
- W3183253339 cites W2217656301 @default.
- W3183253339 cites W2339018270 @default.
- W3183253339 cites W2341290853 @default.
- W3183253339 cites W2469851088 @default.
- W3183253339 cites W2490229867 @default.
- W3183253339 cites W2539965696 @default.
- W3183253339 cites W2562496993 @default.
- W3183253339 cites W2790608652 @default.
- W3183253339 cites W2793669419 @default.
- W3183253339 cites W2793906263 @default.
- W3183253339 cites W2802999346 @default.
- W3183253339 cites W2808937216 @default.
- W3183253339 cites W2809984928 @default.
- W3183253339 cites W2811426626 @default.
- W3183253339 cites W2892233392 @default.
- W3183253339 cites W2895411210 @default.
- W3183253339 cites W2901390964 @default.
- W3183253339 cites W2905287328 @default.
- W3183253339 cites W2908291691 @default.
- W3183253339 cites W2909647845 @default.
- W3183253339 cites W2919341115 @default.
- W3183253339 cites W2943832346 @default.
- W3183253339 cites W2951516500 @default.
- W3183253339 cites W2966025137 @default.
- W3183253339 cites W2986018306 @default.
- W3183253339 cites W2999517198 @default.
- W3183253339 cites W3006340002 @default.
- W3183253339 cites W3012835796 @default.
- W3183253339 doi "https://doi.org/10.1016/j.schres.2021.07.008" @default.
- W3183253339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34304146" @default.
- W3183253339 hasPublicationYear "2021" @default.
- W3183253339 type Work @default.
- W3183253339 sameAs 3183253339 @default.
- W3183253339 citedByCount "6" @default.
- W3183253339 countsByYear W31832533392022 @default.
- W3183253339 countsByYear W31832533392023 @default.
- W3183253339 crossrefType "journal-article" @default.
- W3183253339 hasAuthorship W3183253339A5002643809 @default.
- W3183253339 hasAuthorship W3183253339A5007764412 @default.
- W3183253339 hasAuthorship W3183253339A5029245216 @default.
- W3183253339 hasAuthorship W3183253339A5032603473 @default.
- W3183253339 hasAuthorship W3183253339A5033148517 @default.